Heron Therapeutics reported $-49498000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amarin AMRN:US $ -62.83M 34.52M
Ani Pharmaceuticals ANIP:US $ -12913000 6.28M
Anika Therapeutics ANIK:US $ -3.38M 0.17M
Arrowhead Research ARWR:US $ -72909000 114.46M
Eisai 4523:JP Y 7434M 28237M
Emergent Biosolutions EBS:US $ -72M 78.4M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Immunogen IMGN:US $ -61.05M 38.2M
Insmed INSM:US $ -88316000 1.52M
Ligand Pharmaceuticals LGND:US $ -0.47M 7.34M
Merk MRK:US $ 4927M 642M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Omeros OMER:US $ -37438000 2.39M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Surmodics SRDX:US $ -7.14M 2.24M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Veracyte VCYT:US $ -10.73M 4.51M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M